Colonoscopy has historically been the predominant screening method in the US, while stool tests for occult blood via guaiac testing and fecal immunochemical testing have been preferred in Canada, Europe, and Australia.
In such cases, a colonoscopy would occasionally be performed as a confirmatory procedure following stool sample analyses. Therefore, the colonoscope market has traditionally been focused within the US over most other countries.
Advertisement
As for the market leaders of colonoscopes, they are comprised of mostly top Japanese medical device manufacturers, including Olympus, Fujifilm, and Hoya. However, this list may change by the end of the decade, as Ambu, a Danish company that pioneered single-use endoscopes, is likely to launch the world’s first single-use colonoscope.
By not only eliminating the risk of cross-contamination but also potentially lowering the cost per procedure by using single-use colonoscopes, more companies will likely invest in their research and development (R&D) for manufacturing their single-use colonoscopes.
There is a need for early detection and surgical treatment for colorectal cancer, which is the second deadliest cancer type, remains high. Recent data from sources like the International Agency for Research on Cancer indicate that the annual death count due to colorectal cancer exceeds 600,000, which highlights the importance of detecting this cancerous type at early stages so that suitable treatments can be arranged.
Source: Medindia
Source link
#Forecasting #Global #Colonoscope #Market #Reach
